In this month's issue of Archives, Ferreyra and coworkers1 report their experience treating patients who have autoimmune retinopathy (AIR) with immunosuppression. Included among the 30 patients in their retrospective study were 6 patients with cancer-associated retinopathy, 13 with nonparaneoplastic AIR, and 11 with nonparaneoplastic AIR with cystoid macular edema.
Jampol LM, Fishman GA. Immunosuppression for Autoimmune Retinopathy. Arch Ophthalmol. 2009;127(4):573-575. doi:10.1001/archophthalmol.2009.51